Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2001-2026

i-STAT G3+ cartridge; List Number: 03P78-26; Recall

i-STAT G3+ cartridge; List Number: 03P78-26;

FDA recall Class II

Ongoing

FDA lists this Class II recall for i-STAT G3+ cartridge; List Number: 03P78-26;. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2001-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Apr 1, 2026
FDA report date
May 6, 2026
Quantity in commerce
40275 units (US only)
Distribution
See key details
FDA cause
Process change control

What is being recalled?

i-STAT G3+ cartridge; List Number: 03P78-26;

Affected model & UDI checker

Search the exact identifiers published for Z-2001-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedi-STAT G3+ cartridge; List Number: 03P78-26;Check source notice00054749005673
FDA code information

List Number: 03P78-26; UDI-DI: 00054749005673; Lot number: N25221;

View the original FDA recall notice

Why was this product recalled?

Approximately 7.6% of cartridges from specific i-STAT EG7+ (list number 03P76-25), i-STAT EG6+ (list number 03P77-25) and i-STAT G3+ (list number 03P78-26) cartridge lots in the U.S. marketplace may report higher than expected PCO2 and lower than expected pH results due to a manufacturing issue. A falsely high pCO2 together with a falsely low pH makes the blood gas appear as if the patient is in severe respiratory acidosis. If the clinician believes the values are real, it may trigger unnecessary or even harmful interventions such as unnecessary ventilator changes, unnecessary medications, potential harm from overcorrection, or delays in identifying true problems.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Abbott Point of Care, Inc. take?

On April 1, 2026, URGENT MEDICAL DEVICE CORRECTION letters were sent to customers. This Urgent Medical Device Corrective is to customers in the U.S. with the following recommended actions: " Discontinue use of the affected i-STAT EG7+, EG6+, and G3+ cartridge lots for reporting PCO and pH results. " Use an alternate cartridge type, alternate lot, or testing method. " Complete and return the Business Reply Card included with this notification to confirm receipt and understanding. If you have forwarded any of the specified i-STAT EG7+, EG6+ or G3+ cartridges to another facility, we request that you please provide a copy of this letter to them.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology